Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CTXR | Citius Pharmaceuticals, Inc. | Chief Executive Officer, Director, 10%+ Owner | $7.69M | Nov 7, 2024 | ||
CTOR | CITIUS ONCOLOGY, INC. | Chief Executive Officer, Director | Aug 12, 2024 | |||
THAR | Tharimmune, Inc. | Director | Aug 9, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|